Pregnancy medicines shortage sparks concern The RACGP has joined RANZCOG to address nationwide supply issues related to a lack of clinical trials and off-patent drugs.
Semaglutide shortage prompts caution around off-label prescribing GPs are being asked to prioritise the drug for people with diabetes, but with supplies critically low, what are the alternatives?
Off-label prescribing in the midst of a pandemic: The case of hydroxychloroquine Off-label prescribing of hydroxychloroquine – or the closely related chloroquine – for prophylaxis of COVID-19 raises a number of potential concerns.
Medication management and supply A new RACGP resource is designed to inform GPs and practice staff who already, or wish to, store and supply medicines directly to their patients.
Updated product warnings for Diane-35 Anti-acne medication Diane-35 has received a number of amended warnings detailing an increased risk of blood clots after concerns were raised about its use as an off-label contraceptive.
MP calls for greater pharmacovigilance in Australia Federal MP Julian Hill speaks with newsGP about increased pharmacovigilance in Australia following his daughter’s near-fatal experience with off-label prescribing.